Rutherford Hospital

Az itteni vizsgálatok

Miről szól a helyszín 13 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Gyermekkori daganatok2 vizsgálat
• Petefészekrák2 vizsgálat
• Vastagbélrák2 vizsgálat
• Akut mieloid leukémia (AML)1 vizsgálat
• Áttétes emlőrák1 vizsgálat
• Hasnyálmirigyrák1 vizsgálat
• Krónikus mieloid leukémia (CML)1 vizsgálat
• Melanóma1 vizsgálat
• Mielóma multiplex1 vizsgálat
• Neuroendokrin daganatok1 vizsgálat
• Prosztatarák1 vizsgálat
• Tripla negatív emlőrák1 vizsgálat
• és még 1

Fázis

• 3. fázis10 vizsgálat
• 2. fázis3 vizsgálat

Állapot

• Lezárult7 vizsgálat
• Fut, nem toboroz6 vizsgálat

Fő szponzor

• National Cancer Institute (NCI)11 vizsgálat
• Alliance for Clinical Trials in Oncology1 vizsgálat
• ETOP IBCSG Partners Foundation1 vizsgálat

Futó vizsgálatok

• Fut, nem toboroz

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

  NCT00658814· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

  NCT00644228· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

  NCT00569127· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

  NCT00430183· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia

  NCT00070499· 2. fázis· National Cancer Institute (NCI)· Forrás

Lezárt vizsgálatok

• Lezárult

  Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

  NCT01167712· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

  NCT00861705· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

  NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

  NCT00217737· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

  NCT00066690· 3. fázis· ETOP IBCSG Partners Foundation· Forrás